These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2309693

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Pericardial effusion during the therapy of Crohn's disease with 5-aminosalicylic acid].
    Weber P, Becker EW, Jenss H.
    Dtsch Med Wochenschr; 1988 Nov 18; 113(46):1806-7. PubMed ID: 3191853
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
    Hanauer SB, Krawitt EL, Robinson M, Rick GG, Safdi MA.
    Am J Gastroenterol; 1993 Sep 18; 88(9):1343-51. PubMed ID: 8362827
    [Abstract] [Full Text] [Related]

  • 5. [Acute pancreatitis due to 5-aminosalicylic acid].
    Romero Castro R, Jiménez Sáenz M, Pellicer Bautista FJ, Domínguez Palomo S, Herrerías Gutiérrez JM.
    Rev Esp Enferm Dig; 1991 Mar 18; 79(3):219-21. PubMed ID: 2043409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
    Netzer P.
    Schweiz Med Wochenschr; 1995 Dec 16; 125(50):2438-42. PubMed ID: 8553032
    [Abstract] [Full Text] [Related]

  • 11. [Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
    Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soulé JC, Galmiche JP, Lerebours E, Descos L, Viteau JM.
    Ann Gastroenterol Hepatol (Paris); 1993 Oct 16; 29(5):251-6. PubMed ID: 8250520
    [Abstract] [Full Text] [Related]

  • 12. [Current salazosulfapyridine derivatives in the treatment of Crohn's disease].
    Belaiche J, Delwaide J, Louis E, Gast P.
    Rev Med Liege; 1991 Jan 16; 46(1):16-22. PubMed ID: 2011676
    [No Abstract] [Full Text] [Related]

  • 13. Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
    Dreyling KW, Hoppe U, Peskar BA, Schaarschmidt K, Peskar BM.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Jan 16; 17A():339-43. PubMed ID: 2889333
    [No Abstract] [Full Text] [Related]

  • 14. Fever, vasculitic rash, arthritis, pericarditis, and pericardial effusion after mesalazine.
    Lim AG, Hine KR.
    BMJ; 1994 Jan 08; 308(6921):113. PubMed ID: 8298382
    [No Abstract] [Full Text] [Related]

  • 15. Uncoated versus coated 5-aminosalicylic acid in Crohn's disease.
    Bossi A, Giuliani GE, Del Poggio P, Fenili D, Ragaini S.
    Lancet; 1989 Feb 04; 1(8632):276. PubMed ID: 2563434
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.
    Gross V, Andus T, Fischbach W, Weber A, Gierend M, Hartmann F, Schölmerich J.
    Z Gastroenterol; 1995 Oct 04; 33(10):581-4. PubMed ID: 7502549
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.
    Messori A, Brignola C, Trallori G, Rampazzo R, Bardazzi G, Belloli C, d'Albasio G, De Simone G, Martini N.
    Am J Gastroenterol; 1994 May 04; 89(5):692-8. PubMed ID: 8172139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.